C4X Discovery Taxonomy3
c4xdiscovery.com
5.3 Club score Visit c4xdiscovery.com
What the maker publishes
- Clinical-trial application
- PatientSeek is described as supporting clinical-trial design and companion diagnostics. source
- Collaboration
- C4X Discovery describes a Taxonomy3 collaboration with the GEN-COVID Consortium in Italy to examine COVID-19 genetics. source
- Commercial model
- C4X Discovery says its business model includes pre-clinical licensing deals with pharmaceutical companies. source
- Drug discovery use
- The company says Taxonomy3-derived targets can inform drug discovery and biomarker identification. source
- Genetic analysis
- Taxonomy3 uses mathematical analysis of genetic data to identify disease-causing targets. source
- Headquarters
- Leeds, United Kingdom source
- Omics inputs
- PatientSeek uses genetics and other omics analyses to stratify patients. source
- Partnership contact
- The company invites inquiries about strategic collaboration and technology partnership opportunities. source
- Patient stratification
- PatientSeek is a patient-stratification platform powered by Taxonomy3. source
- Product positioning
- C4X Discovery describes itself as a drug discovery company focused on small-molecule medicines for immuno-inflammatory diseases. source
- Registered office
- C4X Discovery lists its registered office in Leeds, United Kingdom. source
- Taxonomy3 platform
- Taxonomy3 is a target-identification platform based on human genetics. source
Checked against the maker's pages on 14 Nov 2026.